Cutler Group’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-14,569
| Closed | -$17K | – | 2616 |
|
|
2022
Q3 | $17K | Sell |
14,569
-9,454
| -39% | -$11K | ﹤0.01% | 1232 |
|
|
2022
Q2 | $43K | Sell |
24,023
-37,696
| -61% | -$67.5K | ﹤0.01% | 927 |
|
|
2022
Q1 | $124K | Buy |
+61,719
| New | +$124K | 0.01% | 747 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 2918 |
|
|
2021
Q1 | – | Sell |
-9,700
| Closed | -$46K | – | 2864 |
|
|
2020
Q4 | $46K | Sell |
9,700
-6,000
| -38% | -$28.5K | ﹤0.01% | 1036 |
|
|
2020
Q3 | $91K | Buy |
15,700
+1,500
| +11% | +$8.69K | 0.01% | 700 |
|
|
2020
Q2 | $95K | Sell |
14,200
-7,000
| -33% | -$46.8K | 0.01% | 665 |
|
|
2020
Q1 | $134K | Sell |
21,200
-3,700
| -15% | -$23.4K | 0.01% | 535 |
|
|
2019
Q4 | $259K | Buy |
+24,900
| New | +$259K | 0.02% | 444 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 2326 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 2374 |
|
|
2019
Q1 | – | Sell |
-10,628
| Closed | -$190K | – | 2382 |
|
|
2018
Q4 | $190K | Sell |
10,628
-4,972
| -32% | -$88.9K | 0.02% | 412 |
|
|
2018
Q3 | $458K | Sell |
15,600
-2,700
| -15% | -$79.3K | 0.03% | 363 |
|
|
2018
Q2 | $832K | Sell |
18,300
-8,100
| -31% | -$368K | 0.07% | 240 |
|
|
2018
Q1 | $1.39M | Sell |
26,400
-1,123
| -4% | -$59.3K | 0.12% | 127 |
|
|
2017
Q4 | $1.87M | Buy |
27,523
+6,774
| +33% | +$460K | 0.08% | 143 |
|
|
2017
Q3 | $1.71M | Buy |
20,749
+1,066
| +5% | +$87.8K | 0.06% | 172 |
|
|
2017
Q2 | $1.84M | Sell |
19,683
-9,894
| -33% | -$926K | 0.07% | 179 |
|
|
2017
Q1 | $1.88M | Sell |
29,577
-40,040
| -58% | -$2.55M | 0.08% | 182 |
|
|
2016
Q4 | $3.09M | Buy |
69,617
+66,279
| +1,986% | +$2.94M | 0.11% | 95 |
|
|
2016
Q3 | $120K | Sell |
3,338
-13,932
| -81% | -$501K | 0.01% | 1030 |
|
|
2016
Q2 | $236K | Sell |
17,270
-20,713
| -55% | -$283K | 0.01% | 621 |
|
|
2016
Q1 | $729K | Buy |
37,983
+25,846
| +213% | +$496K | 0.05% | 232 |
|
|
2015
Q4 | $424K | Buy |
+12,137
| New | +$424K | 0.02% | 436 |
|